Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 10,861-10,872 of 23,847
Behavioral study icon
CompletedNCT04828226

Clonidine to Prevent Delirium After Electroconvulsive Therapy.

This study is comparing Clonidine with placebo for people with depression, Catatonia, bipolarity, or Delirium Postseizure. Participants receive Clonidine or placebo and complete study visits and assessments.

In Bern
Depression, BipolarityBehavioralOver 18 Years
Countries
Switzerland
Sponsor
Insel Gruppe AG, University Hospital Bern
Condition
Depression, Bipolarity
Device study icon
CompletedNCT04142320

Closed-loop Optimized rTMS for Depression

This study is comparing closed-loop rTMS with Sham rTMS for people with depression. Participants receive closed-loop rTMS or Sham rTMS and complete study visits and assessments.

In Stanford
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression
Drug study icon
CompletedNCT01123408

Clozapine and Olanzapine Treatment of Aggression

This summary needs review. Please check the official study record and contact the research team for details.

In Orangeburg
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Other study type icon
CompletedNCT04325386

Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Catonsville
SchizophreniaOtherFrom 22 Years to 85 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT01639872

Clozapine for Cannabis Use in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garden Grove
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT00029458

Clozapine for Treatment-Resistant Mania

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
BipolarityDrug
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity
Other study type icon
CompletedNCT06610500

Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

In Saint-Etienne
SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00189995

Clozapine IM and Aggression in Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Beersheva
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Israel
Sponsor
Beersheva Mental Health Center
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.